Life and death of β cells in Type 1 diabetes: A comprehensive review
Author:
Funder
NIH
Juvenile Diabetes Research Foundation
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference73 articles.
1. Teplizumab preserves C-peptide in recent-onset Type 1 diabetes: two-year results from the randomized, placebo-controlled protege trial;Hagopian;Diabetes,2013
2. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset Type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders;Herold;Diabetes,2013
3. A single course of anti-CD3 monoclonal antibody hOKT3{gamma}1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of Type 1 diabetes;Herold;Diabetes,2005
4. Teplizumab treatment may improve C-peptide responses in participants with Type 1 diabetes after the new-onset period: a randomised controlled trial;Herold;Diabetologia,2013
5. Anti-CD3 monoclonal antibody in new-onset Type 1 diabetes mellitus;Herold;N. Engl. J. Med.,2002
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimized Magnetically Docked Ingestible Capsules for Non‐Invasive Refilling of Implantable Devices;Advanced Intelligent Systems;2024-07-09
2. Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice;Journal of Clinical Investigation;2024-06-18
3. Biochemical pancreatic β-cell lineage reprogramming: Various cell fate shifts;Current Research in Translational Medicine;2024-03
4. Autoimmune (Type 1) diabetes;The Rose and Mackay Textbook of Autoimmune Diseases;2024
5. Stem cells therapy for diabetes: from past to future;Cytotherapy;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3